There is limited understanding of the effects of major oncogenic pathways and their combinatorial actions on lipid composition and transformation during hepatic tumorigenesis. Here, we report a negative correlation of Wnt/Myc activity with steatosis in human hepatocellular carcinoma (HCC) and perform in vivo functional studies using three conditional transgenic zebrafish models. Double-transgenic zebrafish larvae conditionally expressing human CTNNB1 mt and zebrafish tcf7l2 or murine Myc together with kras v12 in hepatocytes led to severe hepatomegaly and significantly attenuated accumulation of lipid droplets and cell senescence triggered by kras v12 expression alone. UPLC-MS-based, nontargeted lipidomic profiling and transcriptome analyses revealed that Wnt/Myc activity promotes triacylglycerol to phospholipid transformation and increases unsaturated fatty acyl groups in phospholipids in a Ras-dependent manner. Small-scale screenings suggested that supplementation of certain free fatty acids (FA) or inhibition of FA desaturation significantly represses hepatic hyperplasia of double-transgenic larvae and proliferation of three human HCC cells with and without sorafenib. Together, our studies reveal novel Ras-dependent functions of Wnt signaling in remodeling the lipid metabolism of cancerous hepatocytes in zebrafish and identify the SCD inhibitor MK8245 as a candidate drug for therapeutic intervention.
Introduction
Hepatocellular carcinoma (HCC) is one of the most malignant tumor diseases worldwide, causing over 750,000 deaths per year. Despite the rapid advances in surgical techniques and medical discoveries, the overall survival rate and clinical outcomes for patients with HCC remain disappointing (1). The liver is the central organ of metabolism, and the development of HCC is usually associated with subsequent metabolic lesions, including hepatic steatosis (2) . Previous studies have revealed the Ras and PI3K-Akt pathways, which are activated in over 50% of all HCC cases, as major drivers for hepatic tumorigenesis with steatotic features (2) (3) (4) , although the effects of Ras and Akt on tumor lipid metabolism have been reported to diverge in several contexts (5) (6) (7) (8) (9) . In contrast, the Wnt/b-catenin pathway, which is also activated in over 50% of HCC cases, was reported to repress lipogenesis in white adipose tissue (WAT; ref. 10); however, its effects on lipid metabolism in normal and cancerous livers have not been well described. Therefore, the interactions between and roles of these primary oncogenic pathways in hepatic lipid metabolism, along with the dynamic remodeling of lipid composition during hepatic tumorigenesis are of interest.
The components and transcriptional targets (e.g., Myc) of the canonical Wnt signaling pathway are frequently altered and serve as major oncogenic drivers in HCC (11) (12) (13) (14) . Intensive studies have used animal models to decipher Wnt functions in hepatic tumorigenesis; the outcomes have varied in a highly contextdependent manner. For example, mouse models with conditional loss of Axin1 (15) or Apc (16) in hepatocytes experienced HCC, whereas transgenic mice with activation of b-catenin alone experienced hepatomegaly (17, 18) . However, additional expression of or mutation in Hras, Kras, or Met facilitated b-catenin activation to quickly cause HCC (19, 20) , indicating that certain oncogenic roles of canonical Wnt signaling depend on specific molecular backgrounds. Further observations suggest that the canonical Wnt pathway is downregulated in nonalcoholic steatohepatitis (NASH) but upregulated in HCC (21) , implying a complex connection between Wnt signaling and lipid metabolism.
Rodent models are traditionally used to mimic human hepatic steatosis and tumorigenesis. Recently, zebrafish larvae emerged as unique models for studying early-stage hepatic lesions. Their small size and optical transparency allow whole-liver imaging at cellular resolution and high-throughput drug screening (22) . Several zebrafish models of HCC were previously generated via (conditional) expression of (pro-)oncogenes like, kras v12 , Myc, xmrk, and ctnnb1 in hepatocytes (11, 23, 24) . These models developed hepatic hyperplasia before 6 days postfertilization (dpf), and ultimately achieved stable carcinogenesis at later stages, making them valuable resources. Here, we report a negative correlation between Wnt/Myc activity and steatosis in clinical samples and decipher the downstream effects of Wnt signaling on lipid metabolism in zebrafish hepatocytes. We provide morphologic and molecular evidence that Wnt/Myc activity significantly inhibits the aberrant steatosis, remodels the lipid composition, and enhances the hepatic hyperplasia in a Ras-dependent manner. We also performed two small-scale screenings and identified FA desaturation as the most promising therapeutic target for repressing the intensive proliferative responses induced by double oncogenic pathway activation.
Materials and Methods

Human HCC tissue samples
Archival specimens were obtained from 209 patients with HCC who underwent curative resection between 2006 and 2008 at the Liver Cancer Institute, Zhongshan Hospital, Fudan University (Shanghai, China). Ethical approval was obtained from Zhongshan Hospital Research Ethics Committee, and written informed consent was obtained from each patient. The follow-up procedures were described in detail in Supplementary Material and our previous studies (25, 26) . The studies were conducted in accordance with Declaration of Helsinki.
Zebrafish strains and experimentation
Zebrafish embryos, larvae, and adult fish were raised under standard laboratory conditions at 28.5
C. The following zebrafish lines have been described previously: AB wild-type strain, Tg(TCFsiam:eGFP), Tg(TCFsiam:mCherry), Tg(tp1:eGFP), Tg(fabp10a:TetON;TRE:eGFP-kras v12 ), Tg(fabp10a:TetON; TRE: Myc), Tg(fabp10a:dsRed), and Tg(flk1:mCherry; refs. 11, 23, 27, 28) . The following lines were generated via tol2-meidiated transgene integration: Tg(fabp10a:TetON; TRE:GAL4), Tg(TRE: ABC-P2A-tcf7l2), Tg(UAS:Kaede), Tg(TRE:mKate2), Tg(hsp70l: scd-P2A-mKate2)(F 0 ), and scd mutant. All studies involving animal manipulations were approved by the Fudan University Shanghai Medical School Animal Care and Use Committee and followed the NIH guidelines for the care and use of animals. The additional information of transgenic lines, tissue preparation, IHC, BrdUrd labeling, TUNEL staining, lysotracker staining, senescence-associated b-galactosidase (SA-b-gal) assay, Nile red and Oil red O staining, stimulated Raman scattering (SRS) microscopy setup, triglyceride measurement, real-time RT-PCR, lipidomic profiling, RNA sequencing (RNA-seq), FA/compounds screening, and generation of scd-mutant larvae via CRISPR-Cas9 injection were described in detail in Supplementary Material.
Cell lines and experimentation
HCC cell lines Li-7 (TCHu183), Huh7 (TCHu182), and HepG2 (Scsp-510) were obtained from the Cell Bank of Type Culture Collection of Chinese Academy of Sciences, Shanghai Institute of Cell Biology, Chinese Academy of Sciences (Beijing, China) between 2015 and 2016. All cell lines involved in our experiments were reauthenticated by short tandem repeat analysis every 6 months in our laboratory. Mycoplasma testing was detected through LookOut Mycoplasma PCR Detection Kit (Sigma, MP0035). The cells revived from frozen stocks were used within 10 to 20 passages or for no longer than 2 months. Cells were cultured in DMEM (HyClone SH30022.01) supplemented with 10% FBS (Gibco 10099133) at 37 C with 10% CO 2 . The cell proliferation assay was described in detail in Supplementary Material and our previous studies (28) .
Quantification and statistical analysis
Colocalization analysis, area measurements, statistical calculations, and graphs were generated with ImageJ, Microsoft Excel, and GraphPad Prism. Data are expressed as the mean AE SD from at least three samples (N is listed in each figure legend), with statistical differences being determined by one-way ANOVA or one-tailed t test. For Fig. 1B and D and Supplementary Fig. S1A , the statistical significance was evaluated by the x 2 test, and the significance of the effect of parameters on survival was evaluated by the log-rank (Mantel-Cox) test. Overall survival was defined as the interval between HCC resection and death, and patients alive at the end of follow-up were removed. Drug interactions were analyzed by the Chou and Talalay method using the CalcuSyn software program (29) . The combination index (CI) was simulated from each level of fractional effect.
Results
Wnt/Myc activity is associated with less steatosis in human HCC tissue samples
We performed confirmatory expression analyses of active b-catenin (ABC) dephosphorylated on Ser37 or Thr41 and the putative TCF/b-catenin transcriptional target MYC in 209 human HCC tissue samples (26) . Compared with pan-b-catenin antibody staining, ABC antibody staining improved the visual detection of the Wnt-responsive cells in tumor and paratumor tissues. 
Staining on serial sections showed that ABC, MYC, and Ki67, a proliferative marker, were all enriched in tumor tissue compared with paratumor tissue (Fig. 1A) . Tissue microarray analysis suggested that the tumors positively stained by both ABC and MYC occupied 43.8% of all 194 quantifiable samples, and the presences of ABC and MYC were associated with statistical significance (P ¼ 0.004; Fig. 1B ). Interestingly, steatosis, which features an enlarged clear cytoplasm due to the existence of lipid droplets, was frequently observed in both tumor and paratumor tissues. In a few cases, the paratumor tissues with severe steatosis were observed adjacent to ABC þ and/or MYC þ non-steatotic tumor tissues, and the Oil
Red O staining was performed on the preserved frozen sections of selected samples (Fig. 1C) 
Generation of transgenic zebrafish with canonical Wnt signaling activated in hepatocytes
Clinical observations suggested a potential involvement of the Wnt/b-catenin/Myc pathway in regulating hepatic lipid metabolism. Here, we used zebrafish as a model to identify the detailed effects of Wnt activity on lipid accumulation in vivo. Although the canonical Wnt pathway often has conserved roles between zebrafish and mammals (30) , it was unclear whether such conservation exists in the liver.
To achieve better characterization of Wnt-responsive cells in the zebrafish liver, we employed TCFSiam:eGFP (TCF:eGFP) and TCFSiam:mCherry (TCF:mCherry), two widely used transcriptional reporter lines for canonical Wnt activity (27) . We only found a few nonhepatocyte Wnt-responsive cells in normal livers. Those cells were present in fibrocyte-like morphology at 6 dpf into adulthood ( Fig To activate the canonical Wnt signaling pathway in hepatocytes, two stable transgenic zebrafish lines (liver-driver and Wnt-effector) were generated using the TetON system (Fig. 2B ). On the one hand, the liver-driver line was designed to restain the expression of effector genes only in the hepatocytes at the right time. The liver-driver line was generated by integrating a transgenic cascade: fabp10a:TetON; TRE:GAL4-VP16, which expresses the inducible transactivator TetON via the liver-specific fabp10a promoter (31) and subsequently activates expression of GAL4-VP16 and other downstream genes in the effector lines via the TRE promoter in the presence of doxycycline. The F 0 chimera liver-driver lines were crossed to the established effector lines TRE:mKate2 or UAS:Kaede to generate F 1 offspring that may carry fluorescence in the liver for screening purpose ( Supplementary   Fig. S3A ). Interestingly, the expression of mKate2 driven by TRE promoter displayed ubiquitous red fluorescence in the liver, whereas the expression of green Kaede driven by UAS promoter was mosaic and heterogeneous due to the random silencing of UAS promoter in zebrafish genome ( Supplementary  Fig. S3B ). On the other hand, the Wnt-effector line was designed to activate the canonical Wnt signaling pathway after being induced by the liver-driver line in hepatocytes ( Fig. 2B; ref. 14) . The Wnt-effector line was generated by introducing transgenic cascade: TRE:CTNNB1 P33, C37, A41, P45 -P2A-tcf7l2, which expressed human b-catenin carrying four typical mutations reported in HCC whole-genome sequencing and zebrafish tcf7l2 driven by TRE promoter (Fig. 2B ). Crossing the liver-driver with the Wnt-effector resulted in double-transgenic offspring (Tg(Wnt)), which activated the canonical Wnt signaling pathway ectopically in the liver upon doxycycline treatment; TCF:eGFP was crossed to (Tg(Wnt)) for visual confirmation (Fig. 2C ).
Wnt/Myc and Ras activities induce modest to excessive hepatic hyperplasia
The Tg(Wnt) was investigated in parallel with a previously generated zebrafish line fabp10a:TetON; TRE:Myc (Tg(Myc)) that conditionally expresses murine Myc (one of the Wnt target genes) in the liver (11) . For assessing the combinatory roles of multiple oncogenic pathways in lipid metabolism, we also employed a previously generated strain fabp10a:TetON; TRE:eGFP-kras v12 (Tg(Kras)) that conditionally activates Ras signaling (23) , because Ras signaling is frequently altered in human HCC samples (Supplementary Fig. S4A and S4B), and is partially responsible for steatosis during hepatic tumorigenesis (4). Tg(Wnt) and Tg(Myc) were further crossed to Tg(Kras) to generate Tg(Wnt&Kras) and Tg(Myc&Kras) with double oncogenic pathways activated.
All larvae were treated with 40 mg/mL doxycycline from 3 dpf onwards and were used for phenotypic analyses at 6 dpf. Tg(Kras), Tg(Wnt&Kras), and Tg(Myc&Kras) expressed a eGFPfused Kras v12 that was recruited to the cell membrane to allow cell shape observation, and the hepatocytes in Tg(Wnt&Kras) and Tg(Myc&Kras) displayed significant morphologic abnormalities, being transformed from polygons into irregular fusiform cells (Fig. 2D) . To better examine the general effects of different oncogenic pathways on liver morphology, all six groups of larvae were further crossed with LiPan (fabp10a: dsRed) to facilitate observation of liver size and shape (31) . The single transgenic larvae, Tg(Wnt), Tg(Myc), and Tg(Kras), all displayed marginally enlarged livers (Fig. 2E) . In contrast, the double transgenic larvae displayed significant hepatomegaly within 3 days of induction, and both Tg(Wnt&Kras) and Tg(Myc&Kras) caused much more severe and rapid hyperplasia than their single transgenic siblings (Fig. 2E) . Threedimensional (3d) reconstruction via Amira showed that single transgenic larvae only displayed moderate hyperplasia, whereas Tg(Wnt&Kras) and Tg(Myc&Kras) showed the loss of typical liver shape and enlarged hepatic lobes (Fig. 2E) . Meanwhile, BrdUrd labeling suggested that overproliferation was responsible for the hyperplasia in Tg(Wnt), Tg(Myc), Tg(Kras), Tg(Wnt&Kras), and Tg(Myc&Kras), whereas TUNEL staining revealed modestly increased apoptosis in Tg(Wnt), Tg(Myc) with and without Tg(Kras), which only affected a small proportion of hepatocytes ( Fig. 2F; Supplementary  Fig. S5A ).
Wnt/Myc activity represses the extensive hepatic steatosis and senescence triggered by Kras expression
To investigate whether ectopic Wnt/Myc activity affected lipid distribution patterns in the liver with and without Kras expression, a combination of three approaches (Nile red staining, Oil Red O (ORO) staining, and SRS; Supplementary   Fig. S5B ; ref. 32 ) was employed to assess the existence of lipid droplets at 6 dpf. In general, the hepatocytes in control, Tg(Wnt), and Tg(Myc) larvae did not contain many neutral lipids identified by Nile red, ORO, and SRS at 6 dpf. Although the ectopic Wnt and Myc activity alone statistically reduced the number of small lipid droplets, the low level of lipid droplets Figure 2 . Wnt/Myc and Ras activities induce modest to excessive hepatic hyperplasia. A, Lateral views of TCFsiam:eGFP larvae at 6 dpf in bright-field (top), green fluorescent channel (middle), and ORO staining (bottom). Scale bar, 100 mm. Magnification images of livers on the right. B, Schematic diagram of the TetON system with separate liver-driver and Wnt-effector constructs. The liver-specific expression of CTNNB1 mt (ABC) and tcf7l2 in double-transgenic fish harboring both cassettes is activated in the presence of doxycycline. Red amino acids indicate the mutated sites in human b-catenin. C, High-magnification images of TCFsiam:eGFP and Tg(Wnt); TCFsiam:eGFP larval liver with DAPI at 6 dpf, with doxycycline induction initiated at 3 dpf. Scale bar, 40 mm. D, Representative images of optical sections in Tg(Kras), Tg(Wnt&Kras), and Tg(Myc&Kras) larval liver at 6 dpf. Scale bar, 50 mm. E, Representative images of whole livers from the lateral view, screenshots of 3D reconstruction of livers from the front view in control, Tg(Wnt), and Tg(Myc), Tg(Kras), Tg(Wnt&Kras), and Tg(Myc&Kras) at 6 dpf. Scale bar, 50 mm. F, Statistics of liver size (pixels), proliferation, apoptosis. n ¼ 12 per group for each assay; mean AE SD, with statistical differences determined by one-way ANOVA. Ã , P < 0.05; ÃÃ , P < 0.01; ÃÃÃÃ , P < 0.0001. The liver regions are circled in A, C, and E.
in normal hepatocytes precluded us from reaching a clear conclusion ( Fig. 3A and B) . As expected, Tg(Kras) alone triggered intensive accumulation of lipid droplets in zebrafish hepatocytes ( Fig. 3A and B) , providing a lipid-rich context (Fig. 1C) . Significantly, the Kras-induced lipid accumulation was greatly compromised in Tg(Wnt&Kras) and Tg(Myc&Kras), with both the number and size of lipid droplets reduced in hepatocytes ( Fig. 3A and B) . As accumulation of triacylglycerol (TG) is central to replicative senescence (33), we also performed senescence-associated(SA)- b-Gal staining on all six groups [Control, Tg(Wnt), Tg(Myc), Tg(Kras), Tg(Wnt&Kras), Tg(Myc&Kras)], and found that Tg(Kras), but not Tg(Wnt) or Tg(Myc), induced notable cell senescence in the liver; senescence was significantly alleviated in Tg(Wnt&Kras) and Tg(Myc&Kras) (Fig. 3C; Supplementary Fig. S5C ). However, neither supplement of palmitate nor inhibition of lipogenesis via small molecules caused significant effects on the degree of senescence in Tg(Wnt&Kras) and Tg(Myc&Kras) (Supplementary Fig.  S5D ), indicating that the manipulation of lipid metabolism may not have immediate impacts on senescence in these contexts. In addition, the reduced senescence in double transgenic livers was accompanied by increased level of autophagy/lipophagy, as demonstrated via lysosome staining, LC3 staining, and transmission electron microscope (TEM; Supplementary Fig. S5E ), as well as the alternations of mRNA level of autophagy genes ( Supplementary  Fig. S5F ). Interestingly, both inhibition and stimulation of autophagy seemed to repress the hepatic hyperplasia in double transgenic larvae (Supplementary Fig. S5G ), suggesting the potential versatile outcomes by directly targeting autophagy/lipophagy in hepatic tumorigenesis.
Wnt/Myc activity modulates hepatic lipid composition in a Ras-dependent manner
Introduction of Ras oncogenic insult provided a neutral lipidrich environment, allowing us to morphologically observe the potential effects of Wnt signaling on hepatic steatosis. Biochemical assays were performed on livers dissected from the six groups of larvae, and the protein-normalized TG levels in each lysate were assessed. Our results indicated no obvious change in total TG content of Tg(Wnt) and Tg(Myc) livers, whereas Tg(Kras) displayed increased TG amount over twice the control level, and Tg(Wnt&Kras) and Tg(Myc&Kras) significantly attenuated the TG enrichment (Fig. 4A) . These results are consistent with our morphologic observations.
To better describe the alterations in lipid composition, we performed UPLC-MS-based nontargeted lipidomic profiling on 6 dpf larvae, which are ideal "closed systems" with yolk as the constant lipid input (34) . Because Tg(Myc&Kras) displayed a much more pronounced phenotype than Tg(Wnt&Kras) (Fig.  4A) , the analysis was performed on four groups of larvae: control, Tg(Myc), Tg(Kras), and Tg(Myc&Kras) ( Supplementary  Fig. S6A and S6B) . A total of 1,227 lipid species were identified in five main categories: glycerolipids (GL), glycerophospholipids (GP), sterol lipids (ST), sphingolipids (SP), and saccharolipids (SL; Supplementary Tables S2 and S3). The major lipid classes were TG, phosphatidylethanolamine (PE), ceramide and similar sphingolipid (Cer), phosphatidylcholine (PC), diacylglycerol (DG), cholesterol (CHOL), phosphatidylserine (PS), phosphatidylglycerol (PG), phosphosphingolipids (PICer), phosphatidic acid (PA), phosphatidylinositol (PI), monoacylglycerol (MG), sphingomyelin (SM), and cardiolipin (CL). The proportions of these lipid classes in the four larval groups are diagrammed in Fig. 4B , and the detailed statistics are listed in Supplementary Table S4 .
Most lipids maintained relatively constant proportions among control, Tg(Myc), and Tg(Kras). However, TG percentage was reduced from 26.04% AE 1.01% in the control to 20.41% AE 1.03% in Tg(Myc) and raised to 31.16% AE 2.37% in Tg(Kras). The biggest change occurred in Tg(Myc&Kras); TG percentage extensively decreased to 9.54% AE 0.66%, with the lost proportion being mostly occupied by PE (9.98% AE 0.89%-17.66% AE 0.79%), DG (6.41%-0.64% to 12.17% AE 0.54%), and Cer (12.09% AE 1.01%-15.88% AE 0.65%) compared with Tg(Kras) (Fig. 4B) . Statistically significant alteration in abundance of 286 lipids species of variable importance also followed the same trends (Supplementary Table S5 ). For better visualization, a heatmap was generated on the basis of the relative abundances of individual lipids, and it revealed that almost all TG species were reduced specifically in Tg(Myc&Kras), whereas the abundances of DG and PE displayed more complex transformations with the main tendency of increasing (Supplementary Fig. S6C ). A list of representative lipid species (TG, DG, PE, Cer) was also listed as Fig. 4C . The results suggested that Myc significantly promoted a proportional transformation from TG to GP particularly in the Tg(Kras) background.
Closer examinations of the fatty acyl chains' abundance in each lipid category and class were performed (Supplementary Table  S6 ). For better visualization, a heatmap was also generated on the basis of the relative abundances of saturated fatty acyl groups (SFA), monounsaturated fatty acyl groups (MUFA), polyunsaturated fatty acyl groups (PUFA), and fatty acyl groups with different lengths in Tg(Myc), Tg(Kras), and Tg(Myc&Kras) compared with control (Fig. 4D) . Significantly, Tg(Myc&Kras) decreased SFA and increased PUFA in DG, PE, and total GP compared with Tg(Kras) (Fig. 4E) , whereas the alternations in MUFA were not significant, probably because the increased MUFAs were further desaturated to become PUFAs (Fig. 4E) . However, the Tg(Myc) displayed none or even opposite effects on the desaturation of FA compared with wild-type control, indicating the role of Myc in promoting desaturation of DG, PE, and total GP was Ras-dependent (Fig. 4E) . Besides, Tg(Myc&Kras) increased the proportion of shorter chain FA in TG, PE, and Cer compared with Tg(Kras) (Fig. 4E) . Together, the background of Ras activation was required for Myc to increase shorter or unsaturated fatty acyl groups in the zebrafish liver.
Wnt/Myc activity broadly regulates gene expression associated with lipid metabolism
Lipidomic changes were examined by analyzing the expression of genes involved in lipid metabolism. As an initial screening, we performed RNA-seq on four groups of larvae: control, Tg(Myc), Tg(Kras), and Tg(Myc&Kras). The full list of gene expression data with Gene Ontology and KEGG pathway information is attached as Supplementary Table S7 . KEGG pathway analyses on differentially expressed genes indicated that genes in lipid metabolism were significantly affected by Tg(Myc) with and without the Tg(Kras) background (Supplementary Fig. S7A and S7B) . We then manually chose 128 liverenriched genes associated with lipid metabolism (labeled in red in Supplementary Table S7 ) to generate a heatmap based on the relative alterations of individual gene expression in Tg(Myc), Tg(Myc&Kras), and Tg(Kras) compared with control. The heatmap revealed that dynamic alterations occurred in genes responsible for almost all aspects of lipid metabolism, including those involved in TG/DG/GP transformation and FA desaturation/elongation (Supplementary Fig. S7C ).
Nineteen transcripts were verified in dissected livers of the six larval groups via real-time RT-PCR (Supplementary  Table S8 ). Alternations in the TG to DG and DG to GP transformations in Tg(Wnt&Kras) and Tg(Myc&Kras) were supported by increased expression of lipase C (lipca) and choline/ethanolamine phosphotransferase 1 (cept1a) (Fig. 4F) . However, the DG to TG transformation was complex, as two diacylglycerol Wnt/Myc activity regulates hepatic lipid composition and relevant gene expression in a Ras-dependent manner. A, Protein-normalized TG level in livers of 6 dpf control, Tg(Wnt), Tg(Myc), Tg(Kras), Tg(Wnt&Kras), and Tg(Myc&Kras) larvae (n ¼ 3/group). B, Pie charts showing the lipid composition in 6 dpf zebrafish larvae of control, Tg(Myc), Tg(Kras), and Tg(Myc&Kras) (n ¼ 3/assay). All abbreviations are indicated in main text. C, The normalized abundance of significantly altered lipid species in 6 dpf control, Tg(Wnt), Tg(Myc), Tg(Kras), Tg(Wnt&Kras), and Tg(Myc&Kras) larvae. D, The normalized abundance of fatty acyl groups. The purple box shows significantly altered proportion of SFA and PUFA groups in DG, PE, and all GP of control, Tg(Myc), Tg(Kras), and Tg(Myc&Kras). The green box shows significantly altered proportion of fatty acyl groups with different length in TG, PE, and Cer of control, Tg(Myc), Tg(Kras), and Tg(Myc&Kras) (n ¼ 3/assay). E, Statistics of the normalized abundance of fatty acyl groups. F, mRNA expression of relevant lipid metabolism genes in livers of 6 dpf control, Tg(Wnt), Tg(Myc), Tg(Kras), Tg(Wnt&Kras), and Tg(Myc&Kras) larvae (n ¼ 3/assay). All the statistics are represented as mean AE SD, with statistical differences determined by one-way ANOVA. Ã , P < 0.05; ÃÃ , P < 0.01; ÃÃÃ , P < 0.001; ÃÃÃÃ , P < 0.0001. C, control; M, Myc; K, Kras; M.K, Myc&Kras.
acyltransferases (dgat) were differentially regulated with reduced dgat1b but raised dgat2 expression ( Fig. 4F ; Supplementary  Fig. S7D ). In addition, two FA desaturases, stearoyl-CoA desaturase (scd) and fatty acid desaturase 2 (fads2), were upregulated by Wnt/Myc activity upon Ras insult (Fig. 4F) . Moreover, we found that the expressions of FA elongase genes, elovl7b and elovl1a, were reduced, whereas the expressions of genes in mitochondrial/ peroxisome b-oxidation, acetyl-CoA acyltransferase 2 (acaa2) and 3-hydroxybutyrate dehydrogenase 1(bdh1), were increased; this may account for the absence of (very) long-chain fatty acyl groups and the increase of short/medium-chain fatty acyl groups in certain lipid classes (Fig. 4F) .
Free fatty acid supplementary assays and inhibitor screening on transgenic larvae identify desaturation as a potential target to repress hepatic hyperplasia Both lipidomic and transcriptional analyses suggested that activation of the Wnt/Myc signaling upon Ras insult caused alterations in saturation levels and lengths of fatty acyl groups in GP, the major phospholipid. The composition of fatty acyl groups in PE and GP determines the properties and fluidities of cell membrane and, therefore, plays a role in the high levels of mitosis in tumorigenesis (35) .
To assess whether alterations in FA composition via supplementation of certain free fatty acid (FFA) are potentially beneficial for repressing tumorigenesis, we performed a liver size-based screening with eleven common dietary FFAs in our transgenic models. We first showed that the fluorescent fatty acid analogue can be directly injected into the yolk and absorbed by larvae, with a significant amount deposited in the liver (Fig. 5A) . We then injected various FFAs into all six groups of larvae at 3 dpf, and measured the liver sizes at 6 dpf (Fig. 5B) . The dosage was determined by MTD tests to ensure zebrafish would be alive without severe malformation at 6 dpf, and is approximately equivalent to 200 or 50 mg/kg (for palmitic acid and stearic acid) for drug test in mouse. In general, most FFAs did not cause a significant change in liver size; however, arachidonic acid, a-linolenic acid, and g-linolenic acid caused enhanced hyperplasia in Tg(Wnt&Kras) and/or Tg(Myc&Kras), whereas elaidic acid (also a FADS inhibitor) and palmitic acid significantly prohibited hepatomegaly. Additional BrdUrd labeling and TUNEL staining revealed that both decrease in proliferation and increase in apoptosis were responsible for these inhibitory effects (Fig. 5C) .
We further assessed whether modulation of lipid/FA metabolism via inhibitors can repress hepatic hyperplasia in the zebrafish models by performing drug tests with seven prescreened inhibitors: two SCD inhibitors (MK8245 and A939572), two DGAT inhibitors (xanthohumol and T-863), a PPARg inhibitor (BADGE), a microsomal triglyceride transfer protein (MTP) inhibitor lomitapide, and sorafenib as a control (Fig. 5D) . Remarkably, MK8245, one of the SCD inhibitors, displayed a striking ability to inhibit hepatomegaly in both Tg(Wnt&Kras) and Tg(Myc&Kras)), without causing malformation in larvae, and it also moderately reduces the control liver size due to the potential toxicity ( Fig. 5D and E). BrdUrd labeling and TUNEL staining suggest that MK8245 mainly repressed the proliferation of the tumor-forming hepatocytes (Fig. 5E ). Subsequently, we performed a combination assay using sorafenib as the standard drug. We found that MK8245 further repressed the overproliferation in Tg(Wnt&Kras) and Tg(Myc&Kras) liver on the basis of sorafenib treatment ( Fig. 5D  and E; Supplementary Fig. S8A ). Finally, to confirm SCD as a valid target at the genetic level, we generated scd mutant in zebrafish via CRISPR/Cas9 technique ( (Supplementary Fig. S8B; ref. 36) , and the liver sizes from both Tg(Wnt&Kras) and Tg(Myc&Kras) were significantly reduced in heterozygous scd-mutant background (Fig. 5F) ; we also generated a Tol2 expression vector carrying scd-P2A-mKate cascade driven by the hsp70l promoter, and coinjected it into zebrafish zygotes with tol2 transposase mRNA ( Supplementary Fig. S8C) ; the injected Tg(Kras) larvae were heat shocked to induce extra scd expression, and the liver hyperplasia was not significantly promoted ( Supplementary Fig. S8D ).
MK8245 suppresses proliferation of human HCC cells
To evaluate its therapeutic potential in mammalian cells, MK8245 was tested for antiproliferative activity against three human HCC cell lines: Li-7, Huh7, and HepG2. The IC 50 of MK8245 for Li-7, Huh7, and HepG2 after 48-hour incubation was 8.86 AE 1.27 mmol/L, 6.21 AE 0.83 mmol/L, and 12.69 AE 1.08 mmol/L, respectively; the IC 50 of sorafenib for Li-7, Huh7, and HepG2 was 9.91 AE 1.34 mmol/L, 6.32 AE 0.79 mmol/L, and 8.39 AE 1.17 mmol/L, respectively (Fig. 6A) , suggesting that MK8245 displays comparable antiproliferation activity in human HCC cells.
In addition, the MK8245 was evaluated in combination with sorafenib. The two compounds were applied to cell cultures alone or in combination at concentrations close to their IC 50 , followed by a cell viability assay. The results showed that MK8245 further decreased the viability of all three cell lines on the basis of sorafenib treatment (Fig. 6B) , suggesting that prognosis of human patients may benefit from such combinational treatment. Finally, because the MUFA oleate is the major product of SCD activity, we performed a rescue experiment by directly replenishing oleic acid in the culture medium. This significantly neutralized the effects of MK8245, and all three cell lines partially restored their proliferative responses (Fig.  6B ). To further evaluate the effect of combining treatments with MK8245 and sorafenib, the three cell lines were exposed to varying concentrations of MK8245 and sorafenib at fixed ratios of 9:10 in Li-7, 1:1 in Huh7, and 3:2 in HepG2. Cell viability was then assessed and the Fraction effect (Fa)-CI curves for each drug were generated (Fig. 6C) . The averaged CIs for MK8245 and sorafenib at concentrations close to their IC 50 were 1.159 for Li-7 (slight antagonistic effect), 0.782 for Huh7 (moderate synergistic effect), and 1.009 for HepG2 (nearly additive effect), none of which displayed significant synergistic or antagonistic effect (CI < 0.7).
In summary, our studies suggest that the canonical Wnt signaling pathway has profound influences on the lipid metabolism of hepatocytes in a highly context-dependent manner. Investigations using zebrafish indicated that Ras activity, a typical oncogenic and adipogenic event in hepatic tumorigenesis, could serve as a perturbed background necessary for observing the Wnt signaling remodeling of lipid composition. Lipidomic and transcriptional analyses revealed that Wnt/Myc activity significantly promotes a proportional transformation from TG to GP, particularly in the TG-rich background induced by ectopic Ras activity. Small-scale screenings in zebrafish models identified a desaturase inhibitor, MK8245, as an effective reagent to block the hepatic hyperplasia. Taken together, these data reveal the effects of multiple oncogenic pathways on lipid composition and FA desaturation in hyperplasic zebrafish liver, and possibly in human HCC.
Discussion
Canonical Wnt signaling in the liver is partially conserved between zebrafish and mammals
The canonical Wnt signaling pathway is highly conserved throughout vertebrates, and our results revealed both the similarities and differences of Wnt signaling in zebrafish and mammalian livers. On the one hand, most hepatocytes in both mammal and zebrafish do not display canonical Wnt activity, and b-catenin is ubiquitously distributed at the cell surface throughout the entire liver (37, 38) . Consistent with the aberrant Wnt activity in mammalian HCC, we show that ectopic expression of b-catenin and Tcf7l2 in zebrafish livers also induces hyperplasia with or Figure 5 . FFA supplementation and inhibitor screening on transgenic zebrafish larvae. A, An FFA analogue was injected into the yolk sac at 3 dpf (i) and absorbed by the liver at 6 dpf (ii). Scale bar, 100 mm. B, Liver sizes (pixels) of control, Tg(Wnt), Tg(Myc), Tg(Kras), Tg(Wnt&Kras), and Tg(Myc&Kras) (n ¼ 6/group) at 6 dpf, with injection of different FFAs at 3 dpf. C, Statistics of BrdUrd labeling and TUNEL staining in the livers (n ¼ 12/group) with elaidic acid and palmitic acid injected. D, Liver sizes (n ¼ 6/group) at 6 dpf, with treatment of different inhibitors from 3 dpf. sor, sorafenib. E, Statistics of BrdUrd labeling and TUNEL staining in the livers (n ¼ 12/group) after MK8245 and MK8245 þ sorafenib incubation. F, Statistics of liver sizes in control, Tg(Wnt&Kras), and Tg(Myc&Kras) larvae with scd þ/þ or scd þ/À as the genetic background (n ¼ 12/sample). All column data are represented as mean AE SD.
Statistical differences were determined by one-way ANOVA or unpaired t test. Ã , P < 0.05; ÃÃ , P < 0.01; ÃÃÃ , P < 0.001; ÃÃÃÃ , P < 0.0001.
without other oncogenic insult (Fig. 2E) . On the other hand, the Wnt-responsive cells are mostly observed in a subset of perivenous hepatocytes in the mammalian liver (39), but only a few nonhepatocyte Wnt-responsive cells surrounding the main bile duct were detected. Although those cells were stained by an OV6 antibody, with a small subset being GFAP þ ( Supplementary Fig.   S2B and S2F), they are unlikely to be equivalent of mammalian oval cells, due to the significantly different morphology and nonoverlapping with Notch reporter (tp1:eGFP þ ; Supplementary  Fig. S2C; ref. 40 ). The nature of those cells needs further investigation in both normal and regenerating livers.
Remodeling of hepatic lipid metabolism by Wnt signaling is context dependent
The negative correlation of Wnt/Myc activity and steatosis in clinical samples is simulated by combining Tg(Wnt) or Tg(Myc) with Tg(Kras) in zebrafish (Figs. 1C and 3A) . In contrast to WAT, where both the canonical Wnt pathway and Myc activity display clear roles of antiadipogenesis (10, 41) , normal hepatic tissue does not harbor much accumulated neutral lipids in the first place, and the effects of Wnt and Myc on lipid composition are not biologically significant on their own (Fig. 3A) . However, introduction of kras v12 expression creates a lipid-rich environment and enhances the Wnt function in remodeling lipid metabolism, including TG to GP transformation with less saturation and shorter lengths in FA chains. Interestingly, it has been commonly recognized that steatosis in NASH is an important risk factor for HCC. However, we do not routinely observe neutral lipid accumulation in most typical HCC tissues, suggesting that the steatosis may just be a transient state of certain tumor-causing hepatocytes. In the steatotic hepatocytes, spontaneous mutations in the Wnt/Myc pathway may benefit from the TG-rich cellular environment caused by aberrant Ras signaling or activation of other oncogenic signaling pathways, and be more functional in inducing tumorigenesis. Similarly, the antisenescence effect of Wnt/Myc signaling is only observable upon Ras oncogenic insult, because ÃÃÃÃ , P < 0.0001. C, Drug combinational studies and synergy quantification of MK8245 and sorafenib in Li-7, Huh7, and HepG2 cell lines. Compounds were used in combination in a fixed dose ratio for 48 hours, and cell viability was assessed with MTT assay. The IC 50 values and fractional effect versus combination index (Fa-CI) curves were calculated and generated in CalcuSyn software.
normal liver does not contain many senescence cells. However, the hepatic senescence was not affected by manipulating lipid metabolism in double transgenic larvae, suggesting the repression of senescence may not be linked to lipid remodeling at all in our zebrafish models.
How to target the canonical Wnt signaling pathway for HCC treatment?
Cumulative evidence supports the importance of Wnt activity in HCC diagnosis and prognosis (42) . Many efforts have been made to develop therapeutic approaches targeting the Wnt pathway, and several relevant inhibitors or peptide drugs are in clinical trials. However, because the Wnt pathway is necessary for homeostasis in normal tissues, most of these therapies display common adverse effects including fatigue, alopecia, diarrhea, and nausea (42) . In our study, we propose FA desaturation as a potential metabolic weakness featured by hepatocytes carrying aberrant Wnt activity and show that inhibition of FA desaturation via either a drug or genetic approach represses zebrafish hepatic hyperplasia in Tg(Wnt&Kras) and Tg(Myc&Kras) ( Fig. 5D; Supplementary Fig.  S8B ). Notably, neither the scd mutant nor the inhibitor-treated larvae display obvious developmental defects, suggesting that FA desaturation may be a safer target to achieve a balance between antitumor functions and adverse side effects.
Zebrafish drug tests repurpose MK8245 as a candidate drug for treating hepatic tumor
The most prominent candidate drug identified in the smallscale zebrafish screening is the SCD inhibitor MK8245. SCD catalyzes the formation of MUFA (16:1 and 18:1) from SFA and is highly conserved between humans and lower organisms, including zebrafish and fruit flies (43) . Recent studies suggest that SCD is a transcriptional target of the canonical Wnt signaling pathway, and inhibition of SCD activity induces ER stress and apoptosis in several human HCC cells (44, 45) .
Interestingly, the antiproliferation effect of SCD inhibition can be circumvented by lipid scavenging in hypoxic or Ras-driven tumor cells (5) . The SCD inhibitor MK8245 is a liver-targeted medicine for the treatment of diabetes and dyslipidemia currently in stage II clinical trials (46) . In our studies using both zebrafish models and human HCC cells, MK8245 displays antiproliferation effects. Although MK8245 also affects the development of normal hepatocytes, it merits further investigation for its possible effects on hepatic tumorigenesis in mammals.
Altogether, our studies not only improve our understanding of the complex regulatory outputs of primary oncogenic pathways but also demonstrate zebrafish larva as a powerful and convenient in vivo platform for target identification and drug screening. Future work will fully assess the biochemical functions of SCD and MK8245 using mammalian systems, and may lead to future therapies for treating subsets of HCC.
